Nairobi, April 16 -- The African CDC has faulted US biotech firm Moderna for halting its plans to set up a vaccine manufacturing plant in Kenya.

In a statement released on Monday, the African CDC expressed disappointment at Moderna's move, claiming that Covid-19 vaccines were delivered to Africa late, long after they were made available to developed countries.

This delay, it said, had a significant impact on the course of the pandemic and the demand for vaccines.

Moderna cited reduced demand for Covid-19 vaccines in Africa as the reason for its decision. This was even though the plant had said it would produce vaccines beyond Covid-19.

This move is now threatening the country's plan to boost local production and upscale its preparedne...